The Tobacco Industry’s Abuse of Scientific Evidence and Activities to Recruit Scientists During Tobacco Litigation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
South Korea’s state health insurer, the National Health Insurance Service (NHIS), is in the process of a compensation suit against tobacco industry. The tobacco companies have habitually endeavored to ensure favorable outcomes in litigation by misusing scientific evidence or recruiting scientists to support its interests. This study analyzed strategies that tobacco companies have used during the NHIS litigation, which has been receiving world-wide attention. To understand the litigation strategies of tobacco companies, the present study reviewed the existing literature and carried out content analysis of petitions, preparatory documents, and supporting evidence submitted to the court by the NHIS and the tobacco companies during the suit. Tobacco companies misrepresented the World Health Organization (WHO) report’s argument and misused scientific evidence, and removed the word “deadly” from the title of the citation. Tobacco companies submitted the research results of scientists who had worked as a consultant for the tobacco industry as evidence. Such litigation strategies employed by the tobacco companies internationally were applied similarly in Korean lawsuits. Results of tobacco litigation have a huge influence on tobacco control policies. For desirable outcomes of the suits, healthcare professionals need to pay a great deal of attention to the enormous volume of written opinions and supporting evidence that tobacco companies submit. They also need to face the fact that the companies engage in recruitment of scientists. Healthcare professionals should refuse to partner with tobacco industry, as recommended by Article 5.3 of the WHO Framework Convention on Tobacco Control.
Abstract
South Korea’s state health insurer, the National Health Insurance Service (NHIS), is in the process of a compensation suit against tobacco industry. The tobacco companies have habitually endeavored to ensure favorable outcomes in litigation by misusing scientific evidence or recruiting scientists to support its interests. This study analyzed strategies that tobacco companies have used during the NHIS litigation, which has been receiving world-wide attention. To understand the litigation strategies of tobacco companies, the present study reviewed the existing literature and carried out content analysis of petitions, preparatory documents, and supporting evidence submitted to the court by the NHIS and the tobacco companies during the suit. Tobacco companies misrepresented the World Health Organization (WHO) report’s argument and misused scientific evidence, and removed the word “deadly” from the title of the citation. Tobacco companies submitted the research results of scientists who had worked as a consultant for the tobacco industry as evidence. Such litigation strategies employed by the tobacco companies internationally were applied similarly in Korean lawsuits. Results of tobacco litigation have a huge influence on tobacco control policies. For desirable outcomes of the suits, healthcare professionals need to pay a great deal of attention to the enormous volume of written opinions and supporting evidence that tobacco companies submit. They also need to face the fact that the companies engage in recruitment of scientists. Healthcare professionals should refuse to partner with tobacco industry, as recommended by Article 5.3 of the WHO Framework Convention on Tobacco Control.
참고문헌 (14)
- Richard AD, "Product liability", Tob Control, 21(2), pp.227~228 (2012)
- "WHO Framework Convention on Tobacco Control"[URL]
- 이성규, "담배소송과 다국적 담배회사 내부문건 속 국산담배 성분분석", 보건사회연구, 32(3), pp.461~484 (2012), 한국보건사회연구원
- Mayring P, "Qualitative content analysis", Forum Qual Soc Res, 1(2), pp.20~ (2000)
- "Tobacco litigation, intensive battle" (2014)[URL]
- Kim, "Gahap 525054 Damage claim", Briefs, ~ (2014)
- "Cover story — 200,000 cigarettes" (2014)[URL]
- "Science-for-sale. Risk assessment and management commission"[URL]
- Park S, "Analysis of Korean scientists in internal tobacco company documents", J Korean Soc Res Nicotine Tob, 5(1), pp.1~9 (2014)
- Gruning T, "Tobacco industry influence on science and scientists in Germany", Am J Public Health, 96(1), pp.20~32 (2006)
- Tong E, "ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia", Tob Control, 13(Suppl 2), pp.ii118~ii124 (2004)
- Muggli ME, "Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke", Prev Med, 39(3), pp.568~580 (2004)
- Finding an effective strategy to implement the WHO FCTC Article 5.3, "Lee S", Yonsei University, ~ (2012)
- Miura M, "The role of litigation in tobacco control", Salud Publica Mex, 48(Suppl 1), pp.S121~S136 (2006)
